• Yachen Li, Sike Peng, Fangyuan Liang, Suzhen Liu, and Jia Li.
• College of Acupuncture and Orthopedics, Hubei University of Chinese Medicine, Wuhan, China.
• Medicine (Baltimore). 2022 Jul 22; 101 (29): e29218e29218.

BackgroundIrritable bowel syndrome (IBS) is a common functional bowel disorder. Many systematic reviews/meta-analyses indicate that acupuncture and related therapies are effective for IBS. However, the robustness of the results in the systematic reviews and meta-analyses has not been evaluated. This scoping review aims to ascertain the credibility of current evidence of acupuncture therapy for IBS, to provide clinical research investigators with reliable information.MethodsSearches of China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), China Biology Medicine disc (CBMdisc), and Wanfang Database since the establishment of the database to February 2022. Study selection and data extraction will be conducted by 2 reviewers, and the quality will be assessed by 2 trained reviewers. We will use Assessment of Multiple Systematic Reviews-2 (AMSTAR2) for methodological quality assessment, Preferred Reporting Items for Systematic Reviews and Meta-Analyses for report quality assessment, Grading of Recommendations, Assessment, Development, and Evaluation for the quality of evidence assessment, and the Risk of Bias in Systematic Reviews for the bias assessment.ResultsThe results will be published in a peer-reviewed journal.Trial Registration NumberINPLASY202210117.ConclusionThis scoping review will provide comprehensive evidence of acupuncture for patients with irritable bowel syndrome.Ethics And DisseminationThis scoping review does not require ethical approval as it is a secondary assessment of available literature.Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.

20 keywords...

hide…